- Home
- SBFM vs AMBO Comparison
SBFM vs AMBO Comparison
Compare SBFM & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- AMBO
- Stock Information
- Founded
- SBFM 2006
- AMBO 2000
- Country
- SBFM United States
- AMBO United States
- Employees
- SBFM N/A
- AMBO N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- AMBO Other Consumer Services
- Sector
- SBFM Health Care
- AMBO Real Estate
- Exchange
- SBFM Nasdaq
- AMBO Nasdaq
- Market Cap
- SBFM 7.7M
- AMBO 8.8M
- IPO Year
- SBFM N/A
- AMBO 2010
- Fundamental
- Price
- SBFM $1.54
- AMBO N/A
- Analyst Decision
- SBFM Strong Buy
- AMBO
- Analyst Count
- SBFM 1
- AMBO 0
- Target Price
- SBFM $15.00
- AMBO N/A
- AVG Volume (30 Days)
- SBFM 183.7K
- AMBO 5.8K
- Earning Date
- SBFM 08-15-2025
- AMBO 01-01-0001
- Dividend Yield
- SBFM N/A
- AMBO N/A
- EPS Growth
- SBFM N/A
- AMBO N/A
- EPS
- SBFM N/A
- AMBO 0.11
- Revenue
- SBFM $36,234,578.00
- AMBO $9,392,000.00
- Revenue This Year
- SBFM $192.48
- AMBO N/A
- Revenue Next Year
- SBFM N/A
- AMBO N/A
- P/E Ratio
- SBFM N/A
- AMBO $23.27
- Revenue Growth
- SBFM 35.51
- AMBO 2.50
- 52 Week Low
- SBFM $1.17
- AMBO $1.00
- 52 Week High
- SBFM $7.60
- AMBO $5.55
- Technical
- Relative Strength Index (RSI)
- SBFM 57.58
- AMBO 44.99
- Support Level
- SBFM $1.42
- AMBO $2.34
- Resistance Level
- SBFM $1.75
- AMBO $2.70
- Average True Range (ATR)
- SBFM 0.12
- AMBO 0.16
- MACD
- SBFM 0.01
- AMBO 0.01
- Stochastic Oscillator
- SBFM 61.81
- AMBO 47.79
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.